Dr Nadia Maria   Lopes Amorim
Research Associate

Dr Nadia Maria Lopes Amorim

Accredited Practising Dietitian - APD

PhD in Cancer and Metabolism, UNSW Sydney, Australia

MPhil, MSc in Obesity and Hypertension, 2010-2013, UERJ Rio de Janeiro, Brazil

MBA, 2007-2008, FGV/Inst. Oswaldo Cruz, Brazil

Masters in Human Nutrition, 2004-2006, UFLA, Brazil

Bachelor in Nutrition, Hons1, 1999-2003, UFV, Brazil

Medicine & Health
St. George Clin Sch- Operating

I joined the Microbiome Research Centre in 2019, bringing my clinical expertise as a senior dietitian and scientist to investigate the role of the microbiome in liver disease and liver cancer. I have worked as a clinical dietitian since 2003 having extensive experience in metabolic syndrome including diabetes, obesity, and metabolic surgery.

Throughout my career, amongst all my trainings, I worked 4 years with gastrointestinal cancer and inflammatory bowel diseases and developed a unique skill set including patient care, clinical and pre-clinical research, cellular and molecular biology techniques, translating science from bed to bench and vice versa.

During my Doctoral studies at UNSW (2014-18), I worked with a mouse model of diet-induced obesity, investigating the effects of cancer treatment on metabolism and markers of inflammatory response, linked to the metabolic alterations in childhood cancer survivors.

Currently, I am leading a cutting-edge research project using animal models to understand the interplay between diabetes, obesity, and the microbiome as drivers of liver disease and HCC. In the Liver Research Group, I am also leading a clinical project to understand the impact of the Mediterranean diet on the microbiome and immune response in patients with NAFLD liver cirrhosis and HCC.

+61-2-9113 1387
St George Hospital Microbiome Research Centre


  • Journal articles | 2020
    Amorim NML; Kee A; Coster ACF; Lucas C; Bould S; Daniel S; Weir JM; Mellett NA; Barbour J; Meikle PJ; Cohn RJ; Turner N; Hardeman EC; Simar D, 2020, 'Irradiation impairs mitochondrial function and skeletal muscle oxidative capacity: significance for metabolic complications in cancer survivors', Metabolism: clinical and experimental, vol. 103, pp. 154025, http://dx.doi.org/10.1016/j.metabol.2019.154025
  • Conference Abstracts | 2015
    Eslami S; Boysen L; Amorim N; Bould S; Kee A; Lucas C; Johnston K; Cohn R; Hardeman E; Barres R; Simar D, (eds.), 2015, 'Metabolic complications in cancer survivors: role of adipose tissue dysfunction', in Metabolic complications in cancer survivors: role of adipose tissue dysfunction, Keystone Symposia: Systems Biology of Lipid Metabolism, Breckenridge, Colorado, USA, presented at Keystone Symposia: Systems Biology of Lipid Metabolism, Breckenridge, Colorado, USA, 09 February 2015 - 13 February 2015
    Conference Papers | 2013
    Amorim NM; Bassan FB; Araujo LD; Fernandes JF; Rodrigues MD; Valenca DC; Marques RG; Torres MR; Sanjuliani AF, 2013, 'Obstructive Sleep Apnea and Endothelial Dysfunction in Resistant Hypertension', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, New Orleans, LA, presented at American-Heart-Association High Blood Pressure Research Scientific Sessions, New Orleans, LA, 11 September 2013 - 14 September 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000332130700435&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1